The Chain Reaction
Chain Reaction covers pharmaceutical manufacturing, bioprocessing, scale-up strategy, CDMO partnerships, cold chain logistics, quality assurance, validation, smart factories, supply chain resilience and the operational decisions that move therapies from production to patients.
The Role of Regulatory Leadership in Healthcare
Approval alone does not guarantee patient access, and for pharmaceutical leaders, that gap is becoming one of the industry's most pressing challenges. Regulatory strategy can no longer function as a back-end compliance exercise. It now plays a central role in determining how quickly therapies reach patients, how organisations scale across markets, and whether innovation delivers measurable healthcare impact.
In a recent episode of The Chain Reaction podcast, Trisha Pillay spoke with Dineshree Naiker, co-founder of Umsebe Healthcare, about why regulation should be viewed as strategic infrastructure rather than administrative oversight. Drawing on three decades of experience across...
Rebuilding Healthcare Supply Chains in Africa: Lessons from COVID-19 and the Road Ahead
Healthcare systems around the world are facing growing pressure from supply chain disruption, rising costs, regulatory complexity, and persistent medicine shortages. The COVID-19 pandemic exposed just how vulnerable global pharmaceutical and healthcare networks can be, forcing industry leaders to rethink resilience, localisation, and long-term sustainability. At the same time, emerging technologies such as artificial intelligence are beginning to transform how healthcare organisations manage regulation, logistics, and patient access at scale.
In this episode of Chain Reaction, host Trisha Pillay sits down with healthcare strategist, clinician, and Vicore Health CEO Émile Malan to examine the mounting pressures reshaping p...
